Belite Bio’s (BLTE) Buy Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Belite Bio (NASDAQ:BLTE – Free Report) in a report published on Thursday,Benzinga reports. HC Wainwright currently has a $100.00 price target on the stock. Several other research firms have also recently issued reports on BLTE. Benchmark reiterated a “buy” rating and issued a $80.00 price objective […]
HC Wainwright reaffirmed their buy rating on shares of Belite Bio (NASDAQ:BLTE – Free Report) in a report published on Thursday,Benzinga reports. HC Wainwright currently has a $100.00 price target on the stock. Several other research firms have also recently issued reports on BLTE. Benchmark reiterated a “buy” rating and issued a $80.00 price objective […]
